These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11810021)

  • 1. Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy.
    Sheu JR; Hsiao G; Lin WY; Chen TF; Chien YY; Lin CH; Tzeng CR
    J Biomed Sci; 2002; 9(1):17-25. PubMed ID: 11810021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways.
    Sheu JR; Hsiao G; Shen MY; Lin WY; Tzeng CR
    Clin Lab Haematol; 2002 Apr; 24(2):121-9. PubMed ID: 11985559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets.
    Sheu JR; Yeh GC; Fang CL; Lin CH; Hsiao G
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):743-50. PubMed ID: 12409983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the antiplatelet activity of magnesium in human platelets.
    Sheu JR; Hsiao G; Shen MY; Fong TH; Chen YW; Lin CH; Chou DS
    Br J Haematol; 2002 Dec; 119(4):1033-41. PubMed ID: 12472585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
    Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
    Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.
    Sheu JR; Lee CR; Lin CC; Kan YC; Lin CH; Hung WC; Lee YM; Yen MH
    Br J Pharmacol; 1999 Jul; 127(5):1206-12. PubMed ID: 10455267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.
    Sheu JR; Kan YC; Hung WC; Ko WC; Yen MH
    Thromb Res; 1997 Nov; 88(3):259-70. PubMed ID: 9526946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in the antiplatelet effect of C-phycocyanin.
    Chiu HF; Yang SP; Kuo YL; Lai YS; Chou TC
    Br J Nutr; 2006 Feb; 95(2):435-40. PubMed ID: 16469164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
    Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
    J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
    Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
    Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets.
    Sheu JR; Hung WC; Kan YC; Lee YM; Yen MH
    Br J Haematol; 1998 Oct; 103(1):29-38. PubMed ID: 9792285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR
    J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in the antiplatelet activity of midazolam in human platelets.
    Sheu JR; Hsiao G; Luk HN; Chen YW; Chen TL; Lee LW; Lin CH; Chou DS
    Anesthesiology; 2002 Mar; 96(3):651-8. PubMed ID: 11873041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
    Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
    Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.